L-Methylfolate as a Monotherapy for Treatment-Resistant Depression: A Case Study
- PMID: 33132780
- PMCID: PMC7572139
L-Methylfolate as a Monotherapy for Treatment-Resistant Depression: A Case Study
Abstract
This case study examines a 49-year-old Asian American female patient with long-standing fatigue and depression (20 years or more), for which pharmaceutical antidepressant therapies have been ineffective. History, physical examination, laboratory tests, and Genomind Genecept Assay genetic testing were used to determine symptom severity, investigate the presence of organic causes of fatigue, and provide a potential novel monotherapy for depression. Therapeutic intervention included a slow titration of L-methylfolate to an eventual therapeutic daily dose of 15 mg.
Copyright © 2020 InnoVision Professional Media Inc.
References
-
- Malhi GS, Mann JJ. Depression. Lancet. 2018;392(10161):2299-2312. - PubMed
-
- Phillips KA, Nierenberg AA. The assessment and treatment of refractory depression. J Clin Psychiatry. 1994. Feb;55 Suppl:20-26. - PubMed
-
- Thase ME, Rush JA. Treatment-resistant depression. Bloom FE, Kupfer DJ, eds. Psychopharmacology. Raven Press; 1995:1081-1097.
-
- Keller MB. Issues in treatment-resistant depression. J Clin Psychiatry. 2005; 66 Suppl 8:5-12. - PubMed
-
- Rush AJ. STAR*D: what have we learned? Am J Psychiatry. 2007. Feb;164(2):201-204. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Medical